A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment

Clinical trial NCT04634149 · COMPLETED

Trial details

NCT number: NCT04634149
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Moderate Liver Impairment Severe Liver Impairment

Start date: 2020-11-23
Primary completion: 2022-06-02
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.